| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000045644 |
| Receipt No. | R000052107 |
| Scientific Title | The optimal treatment for fresh osteoporotic vertebral fracture with poor prognostic MRI findings |
| Date of disclosure of the study information | 2021/10/10 |
| Last modified on | 2022/10/03 (Ver. 2) |
| Basic information | ||
| Public title | The optimal treatment for fresh osteoporotic vertebral fracture with poor prognostic MRI findings | |
| Acronym | The optimal treatment for fresh OVF with poor prognostic MRI findings | |
| Scientific Title | The optimal treatment for fresh osteoporotic vertebral fracture with poor prognostic MRI findings | |
| Scientific Title:Acronym | The optimal treatment for fresh OVF with poor prognostic MRI findings | |
| Region |
|
|
| Condition | ||
| Condition | osteoporotic vertebral fracture | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate whether a conservative treatment with initial bed rest prevents from vertebral collapse progression and decrease surgical cases in fresh OVF |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | The rate of conservative treatment failure within 6 months. |
| Key secondary outcomes | Fusion rate, progression of vertebral collapse, progression of local kyphosis, decrease in activity of daily living |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who begins to receive conservative treatment within 2 weeks after injury. | |||
| Key exclusion criteria | Secondary osteoporosis patients, high energy injury | |||
| Target sample size | 100 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | University of Tsukuba | ||||||
| Division name | Orthopaedic Surgery | ||||||
| Zip code | 3058575 | ||||||
| Address | 1-1-1 Tennodai, Tsukuba, Ibaraki | ||||||
| TEL | 029-853-3219 | ||||||
| funatoru3@md.tsukuba.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | University of Tsukuba | ||||||
| Division name | Orthopaedic Surgery | ||||||
| Zip code | 3058575 | ||||||
| Address | 1-1-1 Tennodai, Tsukuba, Ibaraki | ||||||
| TEL | 029-853-3219 | ||||||
| Homepage URL | |||||||
| funatoru3@md.tsukuba.ac.jp | |||||||
| Sponsor | |
| Institute | University of Tsukuba |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Osteoporosis Society |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Tsukuba Clinical Research & Development Organization |
| Address | 2-1-1 Amakubo, Tsukuba, Ibaraki |
| Tel | 029-853-3914 |
| t-credo.adm@un.tsukuba.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 82 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | The rate of conservative treatment failure, fusion rate, progression of vertebral collapse, progression of local kyphosis and decrease of activity of daily living will be investigated. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000052107 |